Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis.
Saved in:
| Title: | Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis. |
|---|---|
| Authors: | Patel, Jaydeep1 jmpatel7@gmail.com, Dhingani, Anjali1, Garala, Kevin1, Raval, Mihir2, Sheth, Navin2 |
| Source: | Powder Technology. May2014, Vol. 258, p331-343. 13p. |
| Subjects: | Dosage forms of drugs, Bioavailability, Principal components analysis, Nanostructured materials, Oral medicine, Drug development, Drug design |
| Abstract: | Abstract: Aim of the present investigation was to develop nanoparticulate solid oral dosage forms of a poorly water soluble antihypertensive agent, telmisartan (TLM) by converting the optimized batch of drug loaded nanosuspensions into a tablet dosage form using lyophilization technique. The TLM loaded nanosuspensions were optimized by implementation of 32 full factorial design along with principal component analysis (PCA) with concentration of stabilizer and amount of milling agents as factors. The optimized batch of TLM loaded nanosuspension exhibited a mean particle size of 334.67±10.43nm. The results of various instrumental techniques illustrated retention of drug crystallinity after milling and lyophilization. The results of in vitro drug release study of tablets containing drug nanocrystals revealed remarkable improvement in the dissolution rate as compared to the marketed tablet (Sartel® 20). The results of in vivo pharmacokinetic study on Wister rats revealed 1.5-fold enhancement in oral bioavailability for tablets containing TLM nanocrystals against the marketed tablets. The present study proposed nanosuspension as a suitable approach for developing nanosized solid oral dosage forms of poorly water soluble drugs like telmisartan using design of experiment and principal component analysis as two important paradigms of quality by design technique. [Copyright &y& Elsevier] |
| Copyright of Powder Technology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: egs DbLabel: Engineering Source An: 95630376 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Patel%2C+Jaydeep%22">Patel, Jaydeep</searchLink><relatesTo>1</relatesTo><i> jmpatel7@gmail.com</i><br /><searchLink fieldCode="AR" term="%22Dhingani%2C+Anjali%22">Dhingani, Anjali</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Garala%2C+Kevin%22">Garala, Kevin</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Raval%2C+Mihir%22">Raval, Mihir</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Sheth%2C+Navin%22">Sheth, Navin</searchLink><relatesTo>2</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Powder+Technology%22">Powder Technology</searchLink>. May2014, Vol. 258, p331-343. 13p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Dosage+forms+of+drugs%22">Dosage forms of drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Bioavailability%22">Bioavailability</searchLink><br /><searchLink fieldCode="DE" term="%22Principal+components+analysis%22">Principal components analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Nanostructured+materials%22">Nanostructured materials</searchLink><br /><searchLink fieldCode="DE" term="%22Oral+medicine%22">Oral medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+development%22">Drug development</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+design%22">Drug design</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Abstract: Aim of the present investigation was to develop nanoparticulate solid oral dosage forms of a poorly water soluble antihypertensive agent, telmisartan (TLM) by converting the optimized batch of drug loaded nanosuspensions into a tablet dosage form using lyophilization technique. The TLM loaded nanosuspensions were optimized by implementation of 32 full factorial design along with principal component analysis (PCA) with concentration of stabilizer and amount of milling agents as factors. The optimized batch of TLM loaded nanosuspension exhibited a mean particle size of 334.67±10.43nm. The results of various instrumental techniques illustrated retention of drug crystallinity after milling and lyophilization. The results of in vitro drug release study of tablets containing drug nanocrystals revealed remarkable improvement in the dissolution rate as compared to the marketed tablet (Sartel® 20). The results of in vivo pharmacokinetic study on Wister rats revealed 1.5-fold enhancement in oral bioavailability for tablets containing TLM nanocrystals against the marketed tablets. The present study proposed nanosuspension as a suitable approach for developing nanosized solid oral dosage forms of poorly water soluble drugs like telmisartan using design of experiment and principal component analysis as two important paradigms of quality by design technique. [Copyright &y& Elsevier] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Powder Technology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=95630376 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.powtec.2014.03.001 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 331 Subjects: – SubjectFull: Dosage forms of drugs Type: general – SubjectFull: Bioavailability Type: general – SubjectFull: Principal components analysis Type: general – SubjectFull: Nanostructured materials Type: general – SubjectFull: Oral medicine Type: general – SubjectFull: Drug development Type: general – SubjectFull: Drug design Type: general Titles: – TitleFull: Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Patel, Jaydeep – PersonEntity: Name: NameFull: Dhingani, Anjali – PersonEntity: Name: NameFull: Garala, Kevin – PersonEntity: Name: NameFull: Raval, Mihir – PersonEntity: Name: NameFull: Sheth, Navin IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 05 Text: May2014 Type: published Y: 2014 Identifiers: – Type: issn-print Value: 00325910 Numbering: – Type: volume Value: 258 Titles: – TitleFull: Powder Technology Type: main |
| ResultId | 1 |